<DOC>
	<DOCNO>NCT01699048</DOCNO>
	<brief_summary>Minimally invasive revascularization leave anterior descend artery follow stent implantation versus percutaneous coronary intervention coronary artery bypass patient multi-vessel coronary disease</brief_summary>
	<brief_title>The Comparative Effectiveness Hybrid Revascularization ( MIDCAB Then PCI ) With DES Versus Multivessel DES PCI CABG</brief_title>
	<detailed_description>Prospective , single-center , randomized trial , intend compare three revascularization strategy patient multi-vessel coronary artery disease : 1 . Hybrid approach ( Minimally invasive off-pump revascularization leave anterior descend artery ( LAD ) leave internal mammary artery ( LIMA ) bypass follow consecutive percutaneous coronary intervention ( PCI ) rest artery drug elute stent ( DES ) ( Hybrid group , n=50 ) 2 . Multi-vessel PCI DES ( MV-PCI group , n=50 ) 3 . Coronary artery bypass graft ( CABG ) treatment ( CABG group , n=50 ) PCI Hybrid MV-PCI group perform 2nd generation clinically proven DES ( Xience V , Xience Prime ) . Study objective Compare three different revascularization strategy patient multi-vessel coronary disease The endpoint : The primary endpoint death , MI , stroke , new myocardial ischemia TVR non-TVR 30 day , 12 month 5-year follow-up . The secondary endpoint : Procedural success , Procedural post-procedural blood loss number transfusion , Recovery time , Heart Failure ( New York Heart Association ( NYHA ) ) , life quality assess one life quality questionnaire</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>1 . Multivessel coronary artery disease ≥ 70 % &lt; 96 % artery stenosis ( accord QCA ) 2 . IIV CCS functional class angina 3 . Asymptomatic patient stresstest document ischemia . 4 . Patients 1 month acute myocardial infarction 5 . Ability perform either revascularization method ( Hybrid , MVDPCI , CABG ) . 6 . Consensus treatment strategy member work group , include cardiologist , cardiac surgeon interventional specialist . 7 . Patients must sign informed consent . 1 . Pregnancy . 2 . Acute coronary syndrome . 3 . Previous CABG . 4 . Previous stent thrombosis . 5 . Severe comorbidity high procedural risk either studied strategy . 6 . Severe peripheral artery disease . 7 . Other serious disease limit life expectancy ( e.g . oncology ) 8 . Inability longterm followup . 9 . Participation clinical trial . 10 . Inability take dual antithrombotic therapy . Angiographic exclusion criterion 1 . Critical stenosis ( ≥95 % ) RCA , LAD , CX Intermediate artery , feasible revascularization . 2 . Left main lesion . 3 . Coronary artery occlusion major vessel . 4 . Single vessel disease . 5 . Need emergency revascularization ( Acute MI , ACS etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>CAD , PCI , MIDCAB , CABG</keyword>
</DOC>